Molecular Templates to Present at the Evercore ISI and BMO Healthcare Conferences
November 26 2018 - 04:30PM
Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology
company focused on the discovery and development of the company’s
proprietary engineered toxin bodies (ETBs), which are
differentiated, targeted, biologic therapeutics for cancer, today
announced that its management will provide a corporate update
at the forthcoming Evercore ISI HealthCONx BioPharma, MedTools, and
Devices Conference, and the BMO Capital Markets Prescriptions for
Success Healthcare Conference.
Evercore ISI HealthCONx – BioPharma, MedTools, &
Devices
ConferenceDate:
Wednesday, November
28Time:
7:35 am Eastern TimeLocation:
Boston Harbor
Hotel
Webcast:
http://wsw.com/webcast/evercore2/mtem/
BMO Capital Markets 2018 Prescriptions for Success
Healthcare
ConferenceDate:
Wednesday, December
12Time:
9:00 am Eastern TimeLocation:
The Mandarin Oriental, New
York
About Molecular
Templates Molecular
Templates is focused on the discovery, development and
commercialization of next-generation immunotoxins called Engineered
Toxin Bodies (ETBs) for the treatment of cancers and other serious
diseases. For additional information, please visit Molecular
Templates’ website at www.mtem.com.
Investor Contact: Adam CutlerChief Financial
Officer adam.cutler@mtem.com 862-204-4006
Source: Molecular Templates, Inc.
Molecular Templates (NASDAQ:MTEM)
Historical Stock Chart
From Feb 2024 to Mar 2024
Molecular Templates (NASDAQ:MTEM)
Historical Stock Chart
From Mar 2023 to Mar 2024